Epidemiological consequences of imperfect vaccines for immunizing infections

SIAM Journal on Applied Mathematics

Volumn 74, Issue 6, 2014, Pages 1810-1830

  Magpantay, F M G ^a   Riolo, M A ^a   Domenech De Celles M ^a   King, A A ^a,b   Rohani, P ^a,b  

^a UNIVERSITY OF MICHIGAN   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Age structured population models; Imperfect vaccines; Infectious disease dynamics

Indexed keywords

DISEASE CONTROL; ORDINARY DIFFERENTIAL EQUATIONS; VACCINES;

AGE-STRUCTURED POPULATION MODELS; ANALYTIC EXPRESSIONS; FAILURE PARAMETERS; INFECTIOUS DISEASE; SYSTEM OF ORDINARY DIFFERENTIAL EQUATIONS; SYSTEM OF PARTIAL DIFFERENTIAL EQUATIONS; SYSTEMATIC ANALYSIS; THRESHOLD PARAMETERS;

DISEASES;

EID: 84919968490     PISSN: 00361399     EISSN: None     Source Type: Journal    
DOI: 10.1137/140956695     Document Type: Article

References (20)

1. J. ARINO, C. CONNELL MCCLUSKEY, AND P. VAN DEN DRIESSCHE, Global results for an epidemic model with vaccination that exhibits backward bifurcation, SIAM J. Appl. Math., 64(2003), pp. 260-276.
2. J. ARINO, K. L. COOKE, P. VAN DEN DRIESSCHE, AND J. VELASCO-HERNÁNDEZ, An epidemiology model that includes a leaky vaccine with a general waning function, Discret. Contin. Dyn. Syst. B, 4(2004), pp. 479-495.
3. J. C. BLACKWOOD, D. A. T. CUMMINGS, H. BROUTIN, S. IAMSIRITHAWORN, AND P. ROHANI, Deciphering the impacts of vaccination and immunity on pertussis epidemiology in Thailand, Proc. Natl. Acad. Sci. USA, 110(2013), pp. 9595-9600.
4. C. P. FARRINGTON, On vaccine efficacy and reproduction numbers, Math. Biosci., 185(2003), pp. 89-109.
5. M. G. M. GOMES, L. J. WHITE, AND G. F. MEDLEY, Infection, reinfection, and vaccination under suboptimal immune protection: Epidemiological perspectives, J. Theoret. Biol., 228(2004), pp. 539-549.
6. M. E. HALLORAN, M. HABER, AND I. M. LONGINI, Interpretation and estimation of vaccine efficacy under heterogeneity, Amer. J. Epidemiol., 136(1992), pp. 328-343.
7. J. M. HEFFERNAN AND M. J. KEELING, Implications of vaccination and waning immunity, Proc. Roy. Soc. B., 276(2009), pp. 2071-2080.
8. H. INABA, Threshold and stability results for an age-structured epidemic model, J. Math. Biol., 28(1990), pp. 411-434.
9. W. O. KERMACK AND A. G. MCKENDRICK, A contribution to the mathematical theory of epidemics, Proc. R. Soc. A Math. Phys. Eng. Sci., 115(1927), pp. 700-721.
10. J. S. LAVINE, A. A. KING, V. ANDREASEN, AND O. N. BJØRNSTAD, Immune boosting explains regime-shifts in prevaccine-era pertussis dynamics, PLoS ONE, 8(2013), pp. 1-8.
11. M. Y. LI AND J. S. MULDOWNEY, A geometric approach to global-stability problems, SIAM J. Math. Anal., 27(1996), pp. 1070-1083.
12. A. L. LLOYD, Realistic distributions of infectious periods in epidemic models: Changing patterns of persistence and dynamics, Theor. Popul. Biol., 60(2001), pp. 59-71.
13. A. G. MCKENDRICK, Applications of mathematics to medical problems, Proc. Edinb. Math. Soc., 44(1926), pp. 98-130.
14. A. MCLEAN AND S. M. BLOWER, Imperfect vaccines and herd immunity to HIV, Proc. R. Soc. Lond. B., 253(1993), pp. 9-13.
15. J. MOSSONG, N. HENS, M. JIT, P. BEUTELS, K. AURANEN, ET AL., Social contacts and mixing patterns relevant to the spread of infectious diseases, PLoS Med., 5(2008), 0050074.
16. P. G. SMITH, L. C. RODRIGUES, AND P. M. FINE, Assessment of the protective efficacy of vaccines against common diseases using case-control and cohort studies, Int. J. Epidemiol., 13(1984), pp. 87-93.
17. H. R. THIEME, Disease extinction and disease persistence in age structured epidemic models, Nonlinear Anal., 47(2001), pp. 6181-6194.
18. P. VAN DEN DRIESSCHE AND J. WATMOUGH, Further notes on the basic reproduction number, in Mathematical Epidemiology, F. Brauer, P. van den Driessche, and J. Wu, eds., Springer, New York, 2008, pp. 159-178.
19. H. VON FÖRSTER, Some remarks on changing populations, in The Kinetics of Cellular Proliferation, Grune and Stratton, New York, 1959, pp. 382-407.
20. M. T. WHITE, J. T. GRIFFIN, C. J. DRAKELY, AND A. C. GHANI, Heterogeneity in malaria exposure and vaccine response: Implications for the interpretation of vaccine efficacy trials, Malar. J., 9(2010), p. 82.